Optogenetic Gene Expression Control in Yeast Fermentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current inducible systems in metabolic engineering for controlling gene expression in yeast are limited by the use of chemical inducers and repressors, which are coarse, persistent, and difficult to tune, and do not allow for precise control over enzyme expression levels, especially when dealing with toxic products or competing metabolic pathways.

Innovation Solution

A light-controlled gene expression system using the OptoEXP and OptoINVRT systems, based on the EL222 light-sensitive transcription factor, which enables bidirectional control of gene expression in yeast, allowing for precise tuning of metabolic pathways and separation of growth and production phases using varying light doses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If chemical inducers or repressors are used to control gene expression, then gene expression can be regulated, but the control is coarse and persistent, making it difficult to tune and practically impossible to reverse

Engineering Contradiction:
Improvecontrol precisionVSAvoidtunability
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces chemical induction systems with an optogenetic system using the EL222 transcription factor that responds to light of specific wavelengths. This substitution allows precise, reversible, and tunable control of gene expression through light dosing, overcoming the limitations of chemical inducers which are coarse and persistent. The light-controlled system enables dynamic adjustment of enzyme expression levels during fermentation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes the ability to change light parameters (wavelength, intensity, duration) to precisely control the expression levels of genes in the metabolic pathway. By varying light dosing parameters, the system can tune enzyme expression to optimal levels for different fermentation phases, providing continuous adjustability that chemical systems cannot achieve.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If inducible systems are used to separate cell growth from product formation, then metabolic burden is reduced, but the systems place restrictions on media composition

Engineering Contradiction:
Improveproduct formation efficiencyVSAvoidmedia composition flexibility
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent replaces chemical-inducible systems with light-controlled optogenetic systems. This substitution removes restrictions on media composition because light does not interfere with nutrient availability or metabolic pathways. The EL222 transcription factor can be controlled by light regardless of the carbon source or other media components, providing full flexibility in media design for optimal productivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If chemical inducers are used for gene expression control, then gene expression can be regulated, but the effects are difficult to tune and practically impossible to reverse

Engineering Contradiction:
Improvegene expression controlVSAvoidcontrol reversibility
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent substitutes chemical inducers with light as the control signal. Light provides immediate and reversible control of the EL222 transcription factor, allowing gene expression to be turned on or off dynamically during fermentation. This reversibility enables the system to adapt expression levels in real-time based on fermentation progress, unlike chemical systems where effects are persistent and difficult to reverse.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs periodic light dosing to control gene expression throughout the fermentation process. By applying light in specific patterns and durations, the system can dynamically regulate enzyme expression levels to match the changing metabolic needs of the fermentation, providing temporal control that chemical systems cannot achieve.

Inventive Principle:
Principle #19Periodic action

4Measurement precision

If light-controlled gene expression is implemented, then precise tuning of metabolic pathways is achieved, but system complexity increases

Engineering Contradiction:
Improveexpression level precisionVSAvoidcontrol system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses the EL222 transcription factor as an intermediary between light input and gene expression output. This intermediary component translates light signals into controlled transcriptional activity, providing a biological interface that simplifies the overall control architecture. The EL222 system integrates multiple light-response functions into a single molecular mediator, reducing the need for complex external control mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system enables robust growth on glucose while producing valuable chemicals like lactate or isobutanol by controlling gene expression with light, achieving high yields and optimizing chemical production by varying light schedules during fermentation.

Implementation Method 1

a first sequence comprising a nucleotide sequence that encodes a light-activated transcription factor that binds to promoter sequences and initiates transcription under certain wavelengths of light

Methodology Applied
Scientific EffectPhotoactivation: Photochromism

Data Source

PatentEP3440091B1System and method of optogenetically controlling metabolic pathways for the production of chemicals
Publication Date: 2024.11.20 THE TRUSTEES OF PRINCETON UNIV
  • EP3440091B1 patent drawingFigure 1
  • EP3440091B1 patent drawingFigure 2
  • EP3440091B1 patent drawingFigure 3

AI summary

A system and method for controlling metabolic enzymes or pathways in cells to produce a chemical above the levels of a wild-type strain is disclosed. The system utilizes cells, including yeasts, bacteria, and molds, having at least two genes capable of being controlled bi-directionally with light, where one gene is turned from off to on when exposed to light and another gene is turned from on to off when exposed to light, the two genes reversing when the light is turned off. Cells may utilize any number of sequences that benefit chemical production, including sequences that: encode for constitutive transcription of light-activated transcription factor fusions; encode for a metabolic enzyme; encode for a repressor; induce expression of metabolic enzymes; and an endogenous or exogenous activator expressed by a constitutive promoter, inducible promoter, or gene circuit.